SkyKnight Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$89.4M Hold
8,580,443
94.98% 1
2026
Q1
$102M Hold
8,580,443
95.3% 1
2025
Q4
$85.5M Hold
8,580,443
94.78% 1
2025
Q3
$76.8M Hold
8,580,443
93.94% 1
2025
Q2
$80.9M Hold
8,580,443
94.9% 1
2025
Q1
$93M Hold
8,580,443
94.87% 1
2024
Q4
$81.7M Hold
8,580,443
89.88% 1
2024
Q3
$96.4M Hold
8,580,443
91.35% 1
2024
Q2
$85.8M Hold
8,580,443
91.93% 1
2024
Q1
$98.8M Hold
8,580,443
93.02% 1
2023
Q4
$62.6M Hold
8,580,443
88.9% 1
2023
Q3
$78.1M Sell
8,580,443
-325,627
-4% -$3.9M 91.02% 1
2023
Q2
$108M Hold
8,906,070
93.58% 1
2023
Q1
$111M Hold
8,906,070
92.83% 1
2022
Q4
$171M Hold
8,906,070
95.43% 1
2022
Q3
$167M Hold
8,906,070
96.04% 1
2022
Q2
$161M Buy
8,906,070
+760,499
+9% +$12.3M 94.55% 1
2022
Q1
$131M Buy
8,145,571
+55,838
+0.7% +$1M 91.7% 1
2021
Q4
$198M Buy
+8,089,733
New +$190M 94.33% 1

Other funds holding AHCO

SkyKnight Capital's AHCO Position: Q2 2026 in Review

SkyKnight Capital held its AdaptHealth (AHCO) position steady in Q2 2026 at 8,580,443 shares worth $89.4M. The position accounts for 94.98% of the portfolio, ranked #1.

SkyKnight Capital first reported a position in AHCO in Q4 2021 and has held it in 19 quarters since. The position peaked at $198M in Q4 2021. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • SkyKnight Capital held 8,580,443 shares of AdaptHealth worth $89.4M as of Q2 2026.
  • SkyKnight Capital left its AdaptHealth share count unchanged in Q2 2026.
  • AdaptHealth made up 94.98% of SkyKnight Capital's portfolio in Q2 2026, its #1 holding.
  • SkyKnight Capital first reported a position in AdaptHealth in Q4 2021 and has held it in 19 quarters since.
  • SkyKnight Capital's AdaptHealth position peaked at $198M in Q4 2021.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on SkyKnight Capital's 13F filing for Q2 2026, filed 13 Aug 2026.